Data / Drug companies / Tobramycin and dexamethasone
Tobramycin and dexamethasone: 14 companies and 26 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Tobramycin and dexamethasone is listed in the FDA National Drug Code Directory by 14 companies, with 26 products in commercial distribution. 19 of the products (73.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are suspension/ drops; ointment, and the newest product started marketing on February 26, 2026.
The request: Get every company that lists tobramycin and dexamethasone in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 26
- Generic (ANDA) products
- 19 (73.1%)
- Application numbers
- 4
- Routes
- Ophthalmic
- Brand names
- TobraDex
- openFDA record search
- api.fda.gov
Companies that list tobramycin and dexamethasone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 5 | suspension/ drops | Generic drugs (ANDA) | March 17, 2022 |
| Bryant Ranch Prepack | 3 | suspension/ drops | Generic drugs (ANDA) | March 17, 2022 |
| Bryant Ranch Prepack | 3 | suspension/ drops | Generic drugs (ANDA) | March 17, 2022 |
| NuCare Pharmaceuticals,Inc. | 3 | suspension/ drops | Generic drugs (ANDA) | October 27, 1999 |
| Advanced Rx of Tennessee, LLC | 2 | suspension/ drops | Generic drugs (ANDA) | November 2, 2023 |
| Sportpharm LLC | 2 | suspension/ drops | Generic drugs (ANDA) | October 27, 1999 |
| Bausch & Lomb Incorporated | 1 | suspension/ drops | Generic drugs (ANDA) | October 27, 1999 |
| Bryant Ranch Prepack | 1 | suspension/ drops | Generic drugs (ANDA) | March 17, 2022 |
| Novartis Pharmaceuticals Corporation | 1 | ointment | New drug applications (NDA) | October 15, 1988 |
| Padagis US LLC | 1 | suspension/ drops | Generic drugs (ANDA) | March 17, 2022 |
| Preferred Pharmaceuticals Inc. | 1 | suspension/ drops | Authorized generics (NDA) | February 26, 2026 |
| Redpharm Drug | 1 | suspension/ drops | Generic drugs (ANDA) | March 17, 2022 |
| Remedyrepack Inc. | 1 | suspension/ drops | Authorized generics (NDA) | January 24, 2024 |
| Sandoz Inc | 1 | suspension/ drops | Authorized generics (NDA) | January 2, 2009 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Suspension/ drops | 25 | 96.2% |
| Ointment | 1 | 3.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 19 | 73.1% |
| Authorized generics (NDA) | 6 | 23.1% |
| New drug applications (NDA) | 1 | 3.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Aminoglycoside Antibacterial | 26 |
| Corticosteroid | 26 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.